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Abstract
Moderate alcohol consumption has various effects on immune and inflammatory processes, which could accumulatively modulate chronic
disease risk. So far, no comprehensive, integrative profiling has been performed to investigate the effects of longer-term alcohol consump-
tion. Therefore, we studied the effects of alcohol consumption on gene expression patterns using large-scale profiling of whole-genome
transcriptomics in blood cells and on a number of proteins in blood. In a randomised, open-label, cross-over trial, twenty-four young,
normal-weight men consumed 100 ml vodka (30 g alcohol) with 200 ml orange juice or only orange juice daily during dinner for
4 weeks. After each period, blood was sampled for measuring gene expression and selected proteins. Pathway analysis of 345 down-
regulated and 455 up-regulated genes revealed effects of alcohol consumption on various signalling responses, immune processes and
lipid metabolism. Among the signalling processes, the most prominently changed was glucocorticoid receptor signalling. A network on
immune response showed a down-regulated NF-kB gene expression together with increased plasma adiponectin and decreased
pro-inflammatory IL-1 receptor antagonist and IL-18, and acute-phase proteins ferritin and a1-antitrypsin concentrations (all P,0·05)
after alcohol consumption. Furthermore, a network of gene expression changes related to lipid metabolism was observed, with a central
role for PPARa which was supported by increased HDL-cholesterol and several apo concentrations (all P,0·05) after alcohol consumption.
In conclusion, an integrated approach of profiling both genes and proteins in blood showed that 4 weeks of moderate alcohol consump-
tion altered immune responses and lipid metabolism.
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Moderate alcohol consumption has been consistently associ-
ated with a reduced risk of CVD(1) and type 2 diabetes(2)
compared with abstention. Atherosclerosis, the underlying
cause of many CVD, is increasingly understood to be a
chronic, low-grade inflammatory disease of the arterial
wall(3). Elevated levels of inflammatory markers have been
associated with the risk of CVD(4) and type 2 diabetes(5).
In addition to the improvements in lipid profile, fibrinogen
and insulin sensitivity, alcohol consumption is known to
modulate several immune functions and inflammatory
processes(6,7). In observational studies, moderate alcohol
consumption is indeed associated with lower levels of markers
of systemic inflammation(8) and C-reactive protein(9,10).
Data from randomised trials on inflammatory markers after
prolonged moderate alcohol consumption are scarce but do
suggest lower levels of certain cytokines(11) and C-reactive
protein(12,13), although not consistently(14). Acute moderate
alcohol consumption has been shown to suppress the
production of the pluripotent NF-kB in leucocytes(15,16).
Activation of NF-kB, induced by a wide range of signals
including lipopolysaccharides and viruses, is a pivotal step
in the induction of several inflammatory cytokines, chemo-
kines and growth factors.
Besides their important role in inflammatory responses and
the immune system, leucocytes are also the most readily avail-
able tissue for gene expression profiling. More importantly,
their gene expression profiles have previously been shown
to reflect dietary-induced changes in several short-term and
longer-term intervention trials(17,18). Combining gene and
protein profiling in pathway analyses highly facilitates the
biological interpretation of changes induced by dietary inter-
vention(19). Hence, we analysed gene expression profiles of
leucocytes and several circulating proteins to examine the
effect of moderate alcohol consumption on immune and
inflammation parameters and to explore other potentially
favourable metabolic effects.
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Methods
Study design
The study used a randomised, open-label, cross-over design,
consisting of two 4-week periods. Subjects consumed two
miniatures (50 ml each) of vodka (Smirnoff, Diageo, London,
UK; 30 g alcohol, which corresponds to three Dutch standard
consumption units) with 200 ml orange juice (Appelsientje,
Riedel, Ede, The Netherlands) or only orange juice daily for
4 weeks during dinner. The study was conducted at TNO (a
Dutch acronym for applied scientific research), in Zeist, The
Netherlands. The study was conducted according to the guide-
lines laid down in the Declaration of Helsinki and all pro-
cedures involving human subjects were approved by an
independent centralised ethics committee (METOPP, Tilburg,
The Netherlands). Written informed consent was obtained
from all subjects. The study was registered at Clinicaltrials.gov
(no. NCT00918918). Allocation to treatment order was ran-
domised according to BMI and age. Blood sampling was
done on the morning after 4 weeks of each treatment
period, after an overnight fast. Compliance was monitored
by weekly measurement of urinary ethyl glucuronide (EtG),
a direct phase II metabolite of ethanol formed by the action
of uridine 50-diphospho-glucuronosyl transferase. EtG has
been reported to be a superior marker with 100 % sensitivity
as a biomarker of recent drinking. It persists in the urine up
to approximately 75–85 h after the last intake(20). To assess
unintentional ethanol exposure during the juice intervention
for urinary EtG values, the cut-off limit was set at .0·25 mg/
ml (1·1mmol/l, positive sample). To measure compliance
during the vodka and juice intervention, the cut-off limit was
set at EtG values ,0·5 mg/ml (2·2mmol/l, negative sample).
Additional measures of compliance were the increase in
HDL-cholesterol after alcohol consumption(21) and the return
of empty miniatures of vodka.
Subjects
We recruited twenty-four apparently healthy, non-smoking,
male subjects aged between 21 and 40 years. Subjects were
eligible if they were used to consuming between 5 and
28 units of alcohol per week, were free of any medication at
the beginning of the study, had a BMI between 18 and
27 kg/m2 and had no family history of alcoholism. Subjects
gave written informed consent and received a compensation
for their participation. They were instructed to maintain
their habitual body weight, food pattern and physical
activity pattern, and were told to refrain from any alcoholic
products during the entire study except the vodka supplied
by TNO.
Blood and urine handling and analysis
Blood samples were obtained from the antecubital vein of
the forearm and collected in tubes containing clot activator
for serum and in ice-chilled tubes containing K3EDTA for
plasma (Vacutainer Systems; Becton Dickinson, Plymouth,
UK). Blood was centrifuged for 15 min at 2000g at 48C,
within 15–30 min after collection and stored at ,2708C.
Serum clinical chemistry tests included the measurement of
g-glutamyltransferase, alanine aminotransferase, aspartate
aminotransferase, alkaline phosphatase, glucose, insulin, TAG,
NEFA, total cholesterol, HDL-cholesterol, LDL-cholesterol
and phospholipids and were analysed with enzymatic tech-
niques (Boehringer-Mannheim, Mannheim, Germany) on an
Olympus AU400 clinical chemistry analyser (Olympus-
Diagnostica Europe, Hamburg, Germany). Total adiponectin
was measured using MesoScale Diagnostics assays (catalogue
no. K151IYC-1; Meso Scale Discovery, Gaithersburg, MD,
USA). A total of six serum apo (apoA-I, apoA-II, apoB, apoC-I,
apoC-III and apoE) and forty-seven plasma proteins (Human
InflammationMAPe 1.0; Rules-Based Medicine, Austin, TX,
USA; http://www.rulesbasedmedicine.com/products-services/
Human-InflammationMAP.asp) were analysed using a bead-
based multiplexed immunoassay at the biomarker-testing
laboratory Rules-Based Medicine (Austin, TX, USA). The so-
called 80 % rule was applied to the multiplex protein dataset
to retain only those plasma analytes for which $80 % of the
values were above the detection limit for $ 1 of the two treat-
ment groups(22), resulting in the retention of twenty-nine of the
forty-seven antigens measured in plasma. Values below the
detection limit that remained in the truncated dataset were
replaced by a value of half of the detection limit. Values for
the remaining samples that were not measurable on the stan-
dard curve for a specific protein were set at 0·1 times the detec-
tion limit for that protein. For gene expression analysis, 2·5 ml
blood were collected in PAXgene tubes (Becton Dickinson,
Erembodegem, Belgium) and stored according to the manufac-
turer’s instructions. EtG was determined in morning urine
samples as described previously(23).
RNA extraction, labelling and hybridisation
Microarray hybridisation was performed on RNA extracted
from the whole blood, which was collected at the end of
each 4-week intervention period. RNA was isolated using
the PAXgene Blood RNA Kit (Qiagen, Venlo, The Nether-
lands), according to the manufacturer’s instructions. Quality
control, RNA labelling and hybridisation were performed at
ServiceXS (Leiden, The Netherlands). RNA concentration was
measured using a Nanodrop ND-1000 spectrophotometer
(Nanodrop Technologies, Wilmington, DE, USA). RNA quality
and integrity was determined using Lab-on-Chip analysis on
an Agilent 2100 Bioanalyzer (Agilent Technologies, Inc.,
Santa Clara, CA, USA). Average RNA yield of the samples
was 10·3mg (range 1·9–28mg) and the average RNA integrity
number score was 8·9 (range 6·8–9·6). The labelling reaction
included a globin reduction step. To block the 30 ends of
globin transcripts, four different peptide nucleic acids were
used. Due to the addition of the globin peptide nucleic
acids sequences to the labelling reaction, the labelling of
globin transcripts is hampered in favour of the other tran-
scripts, which are typically under-represented in blood cells.
As a consequence, the signal strength of non-globin genes is
much higher after globin reduction. Biotinylated complemen-
tary RNA was prepared using the Illumina TotalPrep RNA
Amplification Kit (Ambion, Inc., Austin, TX, USA), according
M. M. Joosten et al.2
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
to the manufacturer’s specifications starting with 500 ng total
RNA. For each sample, 750 ng complementary RNA was
used to hybridise to the Sentrix HumanHT-12 v3 Expression
BeadChips (Illumina, Inc., San Diego, CA, USA). Each
BeadChip contains twelve arrays. Hybridisation and washing
were performed according to the Illumina standard assay
procedure. Scanning was performed on the Illumina iScanner
(Illumina, Inc.). Image analysis and the extraction of raw
expression data were performed using Illumina Geno-
mestudio 2010 Gene Expression software (Illumina, Inc.,
San Diego, CA, USA) with background subtraction and no
normalisation. All forty-eight arrays passed the quality-control
criteria. Probe-level data (48 803 probes) were subjected to
quantile normalisation in GeneSpring GX 11.0 (Agilent
Technologies, Santa Clara, CA, USA). Of these, 19 378 probes
were expressed in at least one sample in the present study
(filtering on a detection P value .0·99 in at least one
sample). This set of probes was used for further analysis.
Gene expression data are available in the National Center
for Biotechnology Information (NCBI) Gene Expression
Omnibus (http://www.ncbi.nlm.nih.gov/geo/).
Statistical analysis
Serum and plasma markers with a skewed distribution were
transformed to their natural logarithm for analyses. We used
a mixed-model ANOVA (PROC Mixed procedure in SAS (SAS
Institute, Cary, NC, USA)) that included terms for treatment
(vodka and juice v. juice), period (first v. second), main effects
and the interaction between period and treatment (indicating
possible carry-over effects) to compare variables between the
treatments. No significant (P.0·05) carry-over effects as
assessed by an interaction between treatment and period
effect were observed for any plasma or serum measures.
Statistical analyses were performed using the SAS statistical
software package (SAS version 8.2 and 9.1; SAS Institute).
Statistical significance was defined as P,0·05.
For gene expression data, statistical significance (P,0·05) in
a paired t test was combined with an additional requirement
of either up-regulation in fifteen or more subjects or down-
regulation in fifteen or more subjects. The cut-off of fifteen
subjects was based on the average number of subjects
who showed intervention-induced up- or down-regulation in
significantly changed circulating proteins. The number of the
remaining genes was further reduced by only interpreting
genes that were part of enriched pathways (see the Biological
interpretation section).
Biological interpretation
Functional analysis of the gene expression data was
performed by using Ingenuity Pathway Analysis version 8.7
(Ingenuity Systems, Inc., Redwood City, CA, USA), identifying
significantly enriched pathways and gene lists (P,0·05).
Networks of significantly changed genes and proteins were
Table 1. Overview of differentially expressed pathways and number of genes changed based on Ingenuity Pathway Analysis
(Ingenuity Systems, Inc., Redwood City, CA, USA), ranked on most significantly changed pathway in functional group
Functional group Pathways/lists P Changed genes (n)*
Signalling Glucocorticoid receptor signalling 0·0017 21
Acute myeloid leukaemia signalling 0·0047 9
Oestrogen receptor signalling 0·0151 10
Chronic myeloid leukaemia signalling 0·0158 9
PI3K/AKT signalling 0·0204 10
Neuregulin signalling 0·0288 8
BMP signalling pathway 0·0324 7
GNRH signalling 0·0347 10
G Beta gamma signalling 0·0372 8
Androgen signalling 0·0417 9
Immune response Antigen presentation pathway 0·0028 6
Crosstalk between dendritic cells and natural killer cells 0·0044 10
Leucocyte extravasation signalling 0·0095 15
Oncostatin M signalling 0·0135 5
PKCu, signalling in T-lymphocytes 0·0151 10
GM-CSF signalling 0·0155 7
B-cell receptor signalling 0·0166 12
IL-15 signalling 0·0407 6
T-cell receptor signalling 0·0457 8
Role of NFAT in the regulation of the immune response 0·0468 12
Lipid metabolism/metabolism Mechanism of gene regulation by peroxisome proliferators via PPARa 0·0065 10
Citrate cycle 0·0069 5
PPARa/RXR activation 0·0257 12
Miscellaneous/other Role of NFAT in cardiac hypertrophy 0·0178 14
Selenoamino acid metabolism 0·0214 5
Apoptosis Apoptosis signalling 0·0224 8
Pro-apoptosis 0·0316 5
TNF-R1 signalling 0·0479 5
PI3K, phosphatidylinositol 3-kinase; AKT, serine/threonine kinase (protein kinase B); BMP, bone morphometric proteins; GNRH, gonadotrophin-releasing
hormone; PKCO, protein kinase C theta; GM-CSF, granulocyte-macrophage colony-stimulating factor; NFAT, nuclear factor of activated T-cells; RXR, retinoid X receptor.
*Changed genes selected by statistical significance (P,0·05) in a paired t test combined with an additional requirement of either up-regulation in fifteen or more subjects or
down-regulation in fifteen or more subjects.
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built in MetaCore version 6.1 (GeneGo, St Joseph, MI, USA),
using direct interactions or shortest path algorithm (maximum
two steps and with filter for human data).
Results
Subjects and compliance
All twenty-four men who were enrolled completed the study
without any serious adverse events. Mean age and BMI of
the men were 25·5 (SE 3·3) years and 23·5 (SE 2·5) kg/m2.
Weekly urinary EtG levels were assessed to check individual
compliance to the treatments. This revealed eight positive
urine samples during the orange juice-drinking period,
although all #0·5 mg/ml, and seven negative samples during
the vodka- and juice-drinking periods out of the 192 samples
analysed (overall compliance of 92 %). Another indicator
for compliance was the 8·8 % increase (P,0·001) in HDL-
cholesterol after vodka and juice consumption compared
with juice consumption. Data from all subjects were included
in the analysis since no serious deviations in compliance to the
treatments were observed.
Blood (cell) analysis
The 4 weeks of vodka and juice resulted in a down-regulation
of 382 probes (345 genes with unique Entrez identifier) and
an up-regulation of 492 probes (455 genes with unique
Table 2. Overview of circulating proteins and metabolites that significantly differed (P,0·05) between the two
4-week treatments in twenty-four young men and sampled after an overnight fast
(Mean values with their standard errors)
Orange juice
Vodka and
orange juice
Mean SE Mean SE Percentage change P *
Inflammatory markers
Total adiponectin (mg/ml) 10·5 0·9 11·8 0·9 8·6 ,0·01
IL-1 receptor agonist (pg/ml) 68 5 52 5 213·8 ,0·01
IL-18 (pg/ml) 152 13 143 13 24·0 0·03
Lipoproteins
HDL-cholesterol (mmol/l) 1·12 0·04 1·22 0·05 8·8 ,0·001
Phospholipids (mmol/l) 2·36 0·08 2·52 0·08 6·0 ,0·001
ApoA-II (mmol/l) 12·7 0·7 13·9 0·7 11·6 ,0·01
ApoC-I (mmol/l) 7·2 0·2 7·7 0·2 7·7 0·01
ApoC-III (mmol/l) 9·5 0·7 10·6 0·7 10·4 0·02
Miscellaneous/liver markers
g-Glutamyltransferase (U/l) 19·8 2·4 24·3 2·4 18·7 ,0·001
Ferritin (ng/ml) 125 18 100 18 213·6 ,0·01
a1-Antitrypsin (mg/ml) 1·49 0·05 1·39 0·05 26·0 0·03
*P values obtained from a mixed-model ANOVA.
TAK1(MAP3K7)
Spinophilin
CaMK II
IL-18
CalDAG-GEFII
K-RAS
RASSF5
VAV-3GRB2
IL-2 receptor
IL-2Rβ chain
Adiponectin
Tapasin
β-2-microglobulin HLA-F
IL-15
CSF2RB
NF-κB
c-Raf-1
STAT5A
AML1 (RUNX1)
Ferritin
TIMP2
ITGB1
α-6/β-1 integrin
α-4/β-1 integrin
α-3/β-1 integrin
IL1RN
CXCR4
Fig. 1. Integrated network related to the functional group ‘immune response’ with a central role of NF-kB. The network was derived using MetaCore (GeneGo,
St Joseph, MI, USA) and based on direct interactions between significantly changed expression profiles of forty genes involved in the functional group immune
response and five circulating proteins after 4 weeks of moderate alcohol consumption compared with 4 weeks of abstention. Blue indicates down-regulation in
response to the alcohol intervention and red indicates up-regulation in response to the alcohol intervention. Circles, genes (measured in leucocytes); squares,
plasma proteins. For expansions of gene and protein names, see Supplementary Table 1 (available at http://journals.cambridge.org/bjn).
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Entrez ID) in leucocytes (P,0·05 and up- or down-regulation
observed in at least fifteen subjects). To determine the biologi-
cal role of these genes that were differentially expressed
after vodka and juice consumption in at least fifteen subjects,
we performed pathway analysis using Ingenuity Pathway
Analysis (Ingenuity Systems, Inc.). Significantly enriched
pathways or functional groups (P,0·05) were clustered into
functional groups, indicating an effect of moderate alcohol
consumption on diverse signalling processes, immune
response, lipid metabolism, some miscellaneous processes
and apoptosis in leucocytes (Table 1).
An important functional group that was altered by the alco-
hol treatment compared with the control treatment was
‘immune response’ and consisted of pathways of antigen pres-
entation, B- and T-cell receptor signalling and IL-15 signalling.
The effect of alcohol consumption on immune function was
further analysed by multiplex analysis of inflammatory
plasma proteins. Plasma levels of the positive acute-phase
proteins ferritin and a1-antitrypsin were significantly reduced
as were the levels of the pro-inflammatory cytokines IL-1
receptor antagonist and IL-18 (all P,0·05), whereas plasma
levels of the anti-inflammatory protein adiponectin were
increased after vodka and juice consumption (P,0·01)
(Table 2). These proteins and the set of unique up- and
down-regulated immune response genes were used for
network analysis in MetaCore (GeneGo; Fig. 1). This integra-
tive network analysis of genes and proteins revealed
coherent effects of moderate alcohol consumption on
immune response, as indicated by the direct links between
the genes and proteins in the network. Fig. 1 depicts a
central role for the transcription factor NF-kB, which was
down-regulated after moderate alcohol consumption com-
pared with abstention.
In addition, leucocyte gene expression data also indicated
an effect on gene expression profiles related to lipid
metabolism. Interestingly, serum HDL-concentrations and a
number of other lipid-related parameters, including phospho-
lipids and apoA-II, apoC-I and apoC-III, showed significant
increases in their concentration after vodka and juice con-
sumption (P,0·05; Table 2). These results were integrated
in a network (Fig. 2) that was generated from the set of signifi-
cantly changed markers related to lipid metabolism. Again, this
network approach illustrated close biological links between
the alcohol-induced changes in genes and proteins involved
with a central, albeit putative, role for PPARa.
Among the variety of signalling processes, the most promi-
nently changed was glucocorticoid receptor (GCR) signalling
with a central role for GCRa. Fig. 3 illustrates the inter-
actions between genes associated with glucocorticoid receptor
signalling. The presence of the altered gene expression
profiles of inflammatory factors such as NF-kB and IL-8 in
this pathway again indicated a link to the inflammation modu-
lation by the alcohol intervention. The leucocyte gene
expression data also indicated effects of alcohol on different
Adiponectin
COX-2 (PTGS2)
Bombesin receptor
p53
APOC3
PPAR-α/RXR-α
Pdx-1 (IPF 1)
FATP
ACOX1
LCAT
APOC1
CETP
HDL
APOA2
LIPC (HL)
IDH 1
GLPK
C/EBPβ
G-protein α-q
Fig. 2. Integrated network related to the functional group ‘lipid metabolism’ with a putative role of PPARa. The network was derived using MetaCore (GeneGo,
St Joseph, MI, USA) and based on the shortest path algorithm (maximum two steps) between significantly changed expression profiles of eleven genes involved
in PPAR-regulated pathways or citrate cycle and four circulating proteins after 4 weeks of moderate alcohol consumption compared with 4 weeks of abstention.
Blue indicates down-regulation in response to the alcohol intervention and red indicates up-regulation in response to the alcohol intervention. Circles, genes
(measured in leucocytes); squares, plasma proteins. For expansions of gene and protein names, see Supplementary Table 1 (available at http://journals.
cambridge.org/bjn).
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other signalling processes, including pathways associated with
acute and chronic myeloid leukaemia signalling and apopto-
sis. Since these effects were assumed not to be directly related
to the processes primarily studied, they were not further
analysed.
Discussion
In the present study, we jointly assessed changes in gene
expression and proteins after moderate alcohol consumption
in a randomised cross-over trial in young, normal-weight
men. We showed that 4 weeks of moderate alcohol consump-
tion (30 g alcohol/d) resulted in leucocyte gene expression
changes related to immune response, lipid metabolism, and
a diverse set of signalling pathways and apoptosis. The inte-
grated gene and protein analysis indicated that the alterations
related to immune response were predominantly associated
with a decreased NF-kB expression, whereas changes in
lipid metabolism were closely associated with PPARa.
We observed a down-regulation of NF-kB in leucocytes after
prolonged moderate vodka and juice consumption compared
with consumption of juice only. The various direct connec-
tions of NF-kB with other immune-related gene expression
and protein levels in the immune response network observed
are in accordance with the pleiotropic regulatory function of
NF-kB in inflammatory responses. The present findings of a
down-regulated NF-kB expression after prolonged moderate
alcohol consumption are in concord with observations
ex vivo after acute alcohol administration(16). Moreover, the
network approach predicted that acute alcohol exposure
prevents NF-kB activation, which may lead to an inhibition
in pro-inflammatory cytokines such as C-reactive protein,
TNF-a and IL-1b at the protein as well as the mRNA
level(16). Although these cytokines were not changed in the
present study, we did observe lower levels of the positive
acute-phase proteins ferritin and a1-antitrypsin and pro-
inflammatory cytokines such as IL-1 receptor antagonist and
IL-18 levels after moderate alcohol consumption, in line with
a previous study among diabetic men(24).
The increased total adiponectin concentrations after moder-
ate alcohol consumption are in accordance with two observa-
tional studies(25,26) and other clinical intervention studies
among relatively young and normal-weight men(27) and
women(28). The network analysis shows that adiponectin is
directly related to both the immune response and lipid meta-
bolic changes in response to alcohol consumption. This adds
to the notion that adiponectin might be an important link
between inflammation and lipid metabolism. Indeed, several
lines of evidence suggest an inverse association between adi-
ponectin and markers of inflammation(29) and a positive
association with favourable lipid profiles(30) in observational
studies. Gene expression of the adiponectin gene in leuco-
cytes did not differ between the treatments, despite the
increased protein levels after moderate alcohol consumption.
However, adiponectin is predominantly expressed in adipose
tissue. It has been shown that the alcohol-induced increase of
the protein can largely be attributed to an increased
expression of the adiponectin gene in adipose tissue(23).
A substantial part of changes in gene expression profiles of
the leucocytes found is categorised within the group desig-
nated as signalling. This group included various and divergent
signalling processes. The most significantly altered and
Antileukoproteinase 1
CD 163 PECAM1
IL-8
VIP receptor 1
BAG-1GRB2SMAD7ShcTAK1(MAP3K7)
NF-AT4(NFATC3)
TFIID p53
HNF3-β
C/EBPα
TBP
NCOA3 (pCIP/SRC3)
SF1XPDSRA1
TFTC complex
TAF4 (TAFII130)
TAF5
TAFII150
NF-κB
GCR-α
C/EBPβ AP-1 STAT5
DSIPI (GILZ)
GCR-β
c-Raf-1 K-RAS
Nucleus
Unspecified
Cytoplasm
Membrane
Extracellular
Fig. 3. Network related to glucocorticoid receptor signalling a. The network was derived using MetaCore (GeneGo, St Joseph, MI, USA) and based on the shortest
path (maximum two steps) between significantly changed expression profiles of twenty-one genes after 4 weeks of moderate alcohol consumption compared with
4 weeks of abstention. Blue circles indicate down-regulation in response to the alcohol intervention; red circles indicate up-regulation in response to the alcohol
intervention. For expansions of gene and protein names, see Supplementary Table 1 (available at http://journals.cambridge.org/bjn).
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presumably also most relevant deduced pathway is related to
glucocorticoid receptor signalling. Besides their contribution
to the maintenance of basal and stress-related homeostasis
in all higher organisms, glucocorticoids are part of the feed-
back mechanism in the immune system that turns immune
activity and inflammation down. GCRa is known to exert
these effects by down-regulating the gene expression of NF-
kB(31). The present reported effects of moderate alcohol con-
sumption on inflammatory processes via GCR are thus
in keeping with the existing literature and extend this by
shedding light on how alcohol consumption could suppress
gene expression of NF-kB and other related genes in this
signalling pathway.
We found a substantial decrease in plasma ferritin concen-
trations after the vodka and juice treatment compared with
the control treatment. Ferritin is one of the key proteins
regulating Fe homeostasis. Growing evidence has shown
that even moderately increased Fe stores, represented by
high-normal ferritin concentrations, are associated with insulin
resistance(32) and type 2 diabetes. The results of the present
randomised trial are in contrast with observational research
that shows a positive association with alcohol consumption
and ferritin concentrations(33,34). Gene expression of ferritin
in the leucocytes did not change between the treatments,
probably because the protein is predominantly expressed in
liver tissue.
The strengths of the study are its randomised, cross-over
design, the high compliance to the treatments throughout
the study and the integrated approach of both gene
expression profiles and proteins. However, several limitations
warrant consideration. First, whole blood was collected for
RNA isolation. Since globin RNA was removed from the
samples, it is assumed that the remaining RNA only rep-
resented the gene expression profiles of the leucocytes. More-
over, as the leucocyte population consists of a range of cell
types (e.g. lymphocytes, neutrophils, monocytes, eosinophils
and basophils), we checked whether the observed changes
in gene expression might be due to changes in leucocyte
distribution. However, no differences between the treatments
were observed in the distribution of leucocyte types (data not
shown). Second, we used circulating leucocytes for gene
expression profiling. Although these cells might not be repre-
sentative for all tissues directly affected by alcohol consump-
tion (e.g. liver and adipose tissue), leucocytes were chosen
because of their important roles in inflammatory responses
and the immune system. Furthermore, their expression pro-
files have previously been shown to reflect metabolic changes
due to short-term and longer-term nutritional adaptation in
healthy human subjects(18,19). Third, analysis of plasma and
serum proteins was not as unbiased as the gene expression
analysis (whole-genome microarrays) since we predominantly
measured specific proteins based on a priori expected
changes in inflammatory markers and lipoproteins. We did
aim to include a rather broad range of inflammatory markers
by using a multiplex analysis of forty-seven inflammatory
proteins and six apo. Integration of these protein data with
gene expression data into networks revealed coherent
effects (shown by the direct connections in both the
immune response and lipid metabolism network), which
underlines the close biological connection between the
changes in genes and proteins due to moderate alcohol con-
sumption. Nevertheless, although not entirely unexpected,
we did not observe an association between the changes in
the predominantly lipid- and liver-related protein levels and
changes in the mRNA levels of the leucocytes as measured
with the microarrays. Fourth, we investigated relatively
young, normal-weight and non-smoking subjects who were
at low risk for developing chronic diseases. Perhaps slightly
overweight, middle-aged subjects would have been even
more susceptible to the alcohol-induced changes. However,
inflammatory markers(13) and biological markers such as
HDL-cholesterol and total adiponectin associated with dis-
eases have previously been shown to improve after moderate
alcohol consumption even in these young and relatively
healthy groups(27,28). Moreover, the association between mod-
erate alcohol consumption and the risk of CVD(35) and type 2
diabetes(36) also holds among subjects already at low risk on
the basis of their multiple, favourable lifestyle behaviours.
In conclusion, a comprehensive and integrated approach of
both gene and protein profiling of blood showed that moder-
ate alcohol consumption resulted in changes in immune
response and lipid metabolism. Our integrated and large-
scale profiling revealed potential new functional pathways
and physiological mechanisms that may explain some of the
health effects that moderate alcohol consumption exerts.
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